ATE181324T1 - Im kardiovaskulären system aktive seco-d-steroide und diese enthaltende pharmazeutische zubereitungen - Google Patents
Im kardiovaskulären system aktive seco-d-steroide und diese enthaltende pharmazeutische zubereitungenInfo
- Publication number
- ATE181324T1 ATE181324T1 AT96830206T AT96830206T ATE181324T1 AT E181324 T1 ATE181324 T1 AT E181324T1 AT 96830206 T AT96830206 T AT 96830206T AT 96830206 T AT96830206 T AT 96830206T AT E181324 T1 ATE181324 T1 AT E181324T1
- Authority
- AT
- Austria
- Prior art keywords
- seco
- containing same
- pharmaceutical preparations
- cardiovascular system
- preparations containing
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D307/40—Radicals substituted by oxygen atoms
- C07D307/42—Singly bound oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D307/40—Radicals substituted by oxygen atoms
- C07D307/46—Doubly bound oxygen atoms, or two oxygen atoms singly bound to the same carbon atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D307/52—Radicals substituted by nitrogen atoms not forming part of a nitro radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D307/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Furan Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT95RM000303A IT1282286B1 (it) | 1995-05-11 | 1995-05-11 | Seco-d steroidi sul sistema cardiovascolare, processi per la loro preparazione e composizioni farmaceutiche che li contengono. |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE181324T1 true ATE181324T1 (de) | 1999-07-15 |
Family
ID=11403363
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT96830206T ATE181324T1 (de) | 1995-05-11 | 1996-04-11 | Im kardiovaskulären system aktive seco-d-steroide und diese enthaltende pharmazeutische zubereitungen |
Country Status (10)
Country | Link |
---|---|
US (1) | US5731345A (de) |
EP (1) | EP0742214B1 (de) |
JP (1) | JPH09291086A (de) |
AT (1) | ATE181324T1 (de) |
CA (1) | CA2174715A1 (de) |
DE (1) | DE69602886T2 (de) |
DK (1) | DK0742214T3 (de) |
ES (1) | ES2133918T3 (de) |
GR (1) | GR3031118T3 (de) |
IT (1) | IT1282286B1 (de) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19633376A1 (de) * | 1996-08-19 | 1998-02-26 | Sigma Tau Ind Farmaceuti | Neue Seco-D-Steroide, die auf das kardiovaskuläre System wirken, Verfahren zu ihrer Herstellung und pharmazeutische Zusammensetzungen, die sie enthalten |
CA2330611A1 (en) | 1998-05-22 | 1999-12-02 | The Board Of Trustees Of The Leland Stanford Junior University | Bifunctional molecules and therapies based thereon |
DE60234057D1 (de) | 2001-07-25 | 2009-11-26 | Raptor Pharmaceutical Inc | Zusammensetzungen und verfahren zur modulation des transports durch die blut-hirn-schranke |
US20040064050A1 (en) * | 2002-09-20 | 2004-04-01 | Jun Liu | System and method for screening tissue |
EP1889198B1 (de) | 2005-04-28 | 2014-11-26 | Proteus Digital Health, Inc. | Pharma-informatiksystem |
JP2009508494A (ja) | 2005-09-16 | 2009-03-05 | ラプトール ファーマシューティカル インコーポレイテッド | Crを含むタンパク質に対して特異的な受容体−結合タンパク質(rap)変異体を含む組成物およびその使用 |
WO2007060206A2 (en) * | 2005-11-25 | 2007-05-31 | Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. | Further crystalline forms of rostafuroxin |
DK3395372T3 (da) | 2009-02-20 | 2022-04-19 | Enhanx Biopharm Inc | System til afgivelse af glutathion-baseret medikament |
EP2427178B1 (de) | 2009-05-06 | 2023-01-04 | Laboratory Skin Care, Inc. | Dermale freisetzungszusammensetzung mit wirkstoff-calciumphosphat-partikelkomplexen und anwendungsverfahren |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE4221538C1 (de) * | 1992-07-01 | 1994-03-31 | Sigma Tau Ind Farmaceuti | 14-Desoxy-14alpha-cardenolid-3beta-thioderivate |
DE4221636C1 (de) * | 1992-07-01 | 1994-03-31 | Sigma Tau Ind Farmaceuti | Cyclopentanperhydrophenanthren-17beta-(3-furyl)-3-Derivate |
DE4227605C2 (de) * | 1992-08-20 | 1995-02-16 | Sigma Tau Ind Farmaceuti | 17-Hydroxyiminomethyl-14beta-hydroxy-5ß-androstan-Derivate, Verfahren zu deren Herstellung und pharmazeutische Zusammensetzungen, die dieselben enthalten |
-
1995
- 1995-05-11 IT IT95RM000303A patent/IT1282286B1/it active IP Right Grant
-
1996
- 1996-04-11 AT AT96830206T patent/ATE181324T1/de not_active IP Right Cessation
- 1996-04-11 DE DE69602886T patent/DE69602886T2/de not_active Expired - Fee Related
- 1996-04-11 EP EP96830206A patent/EP0742214B1/de not_active Expired - Lifetime
- 1996-04-11 ES ES96830206T patent/ES2133918T3/es not_active Expired - Lifetime
- 1996-04-11 DK DK96830206T patent/DK0742214T3/da active
- 1996-04-15 US US08/632,124 patent/US5731345A/en not_active Expired - Fee Related
- 1996-04-22 CA CA002174715A patent/CA2174715A1/en not_active Abandoned
- 1996-04-26 JP JP8106864A patent/JPH09291086A/ja active Pending
-
1999
- 1999-08-31 GR GR990402200T patent/GR3031118T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
EP0742214A1 (de) | 1996-11-13 |
CA2174715A1 (en) | 1996-11-12 |
DE69602886D1 (de) | 1999-07-22 |
US5731345A (en) | 1998-03-24 |
ES2133918T3 (es) | 1999-09-16 |
ITRM950303A0 (it) | 1995-05-11 |
EP0742214B1 (de) | 1999-06-16 |
DK0742214T3 (da) | 1999-12-13 |
ITRM950303A1 (it) | 1996-11-11 |
DE69602886T2 (de) | 1999-11-04 |
IT1282286B1 (it) | 1998-03-16 |
JPH09291086A (ja) | 1997-11-11 |
GR3031118T3 (en) | 1999-12-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU7576896A (en) | Lipopolyamines as transfection agents and their pharmaceutical applications | |
AU2724292A (en) | Antiviral 4-substituted-2-deoxy-2,3-didehydro-derivatives of alpha-d-neuraminic acid | |
HK1036931A1 (en) | Pharmaceutical compositions containing compounds with activity for the enhancement of absorption of active ingredients. | |
DE69604653T2 (de) | Taxol derivate, deren herstellung und diese enthaltende pharmazeutischen zusammenstellungen | |
FI973828A0 (fi) | Yhdisteitä ja koostumuksia aktiivisten aineiden annostelemiseksi | |
CA2201477A1 (en) | New pyrimidone derivatives with antifungal activity | |
TR199801179T2 (xx) | Yeni taksoitler, bunlar�n haz�rlanmalar� ve ila� bile�imleri. | |
AU697679B2 (en) | Treatment of tinnitis using neuroprotective agents | |
HRP930239A2 (en) | Anti-inflamatory 4-aminophenol derivatives | |
CA2254079A1 (en) | Androstene derivatives | |
WO1997004788A3 (en) | Use of calendula glycosides for the treatment of psoriasis | |
CA2152771A1 (en) | 7-o-ethers of taxane derivatives | |
HK1009139A1 (en) | New 6-hydroxy and 6-oxo-androstane derivatives active on the cardiovascular system and pharmaceutical compositions containing same | |
ATE181324T1 (de) | Im kardiovaskulären system aktive seco-d-steroide und diese enthaltende pharmazeutische zubereitungen | |
DE4493718T1 (de) | Abbaubare Succinsäurederivatchelanten, Verwendungen und Zusammensetzungen davon | |
DE69624308T2 (de) | Bernsteinsäurederivate als abbaubare Chelatbildner, ihre Verwendungen und Zusammensetzungen | |
TR200000291T2 (tr) | Taşikinin reseptör antagonistleri olarak 2-asilaminopropanaminler. | |
DE69310052D1 (de) | Kardioaktive 17B-(3-Furyl) und 17B-(4-Pyridazinyl)-5beta, 14beta-Androstan Derivate, Verfahren zu ihrer Herstellung und pharmazeutische Präparate davon | |
DE69407057T2 (de) | 1,3.5 (10) - estratriene derivate mit oraler wirkung | |
FI923751A0 (fi) | Hexahydrobenso/f/kinolinoner. | |
GEP20032975B (en) | Echinocandin Derivatives, Preparation Method and Pharmaceutical Composition | |
AU4318397A (en) | Novel 2,4-dioxopyrrolidine and 2,4-dioxotetrahydrofuran derivatives and medicines containing the same as the active ingredient | |
DE69603793T2 (de) | Kardioaktive 17-Hydroxyiminoalkyl- und 17-Hydroxyiminomethylalkenyl-Steroid-Derivate, ein Verfahren zu ihrer Herstellung und pharmazeutische Präparate davon | |
ITMI920076A1 (it) | Composti steroidei 17-aril-sostituiti attivi sul sistema cardiovascolare | |
ATE203530T1 (de) | Adamantyl substituierte oxindole als pharmazeutische wirkstoffe |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification | ||
REN | Ceased due to non-payment of the annual fee |